CRINETICS Trademark

Trademark Overview


On Thursday, April 12, 2018, a trademark application was filed for CRINETICS with the United States Patent and Trademark Office. The USPTO has given the CRINETICS trademark a serial number of 87875063. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 19, 2022. This trademark is owned by Crinetics Pharmaceuticals, Inc.. The CRINETICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to treat or prevent dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to target neuropeptide receptors; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinis...

Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, co...
crinetics

General Information


Serial Number87875063
Word MarkCRINETICS
Filing DateThursday, April 12, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to treat or prevent dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to target neuropeptide receptors; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain
Goods and ServicesMedical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 21, 2018
Primary Code005
First Use Anywhere DateWednesday, May 12, 2021
First Use In Commerce DateWednesday, May 12, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 21, 2018
Primary Code042
First Use Anywhere DateWednesday, May 12, 2021
First Use In Commerce DateWednesday, May 12, 2021

Trademark Owner History


Party NameCrinetics Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameCrinetics Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, July 19, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, July 19, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, January 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 5, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 5, 2022SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 30, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, October 29, 2021USE AMENDMENT FILED
Friday, October 29, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, May 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 7, 2021SOU EXTENSION 5 GRANTED
Thursday, April 29, 2021SOU EXTENSION 5 FILED
Friday, May 7, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 29, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020SOU EXTENSION 4 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 4 FILED
Wednesday, October 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2020SOU EXTENSION 3 GRANTED
Friday, April 24, 2020SOU EXTENSION 3 FILED
Friday, April 24, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2019SOU EXTENSION 2 GRANTED
Monday, October 21, 2019SOU EXTENSION 2 FILED
Monday, October 21, 2019SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 17, 2019SOU EXTENSION 1 GRANTED
Wednesday, April 17, 2019SOU EXTENSION 1 FILED
Wednesday, April 17, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, April 17, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 17, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 31, 2018ASSIGNED TO EXAMINER
Saturday, April 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 16, 2018NEW APPLICATION ENTERED